Annual Current Liabilities
$110.85 M
-$4.36 M-3.78%
December 31, 2024
Summary
- As of March 12, 2025, NTLA annual total current liabilities is $110.85 million, with the most recent change of -$4.36 million (-3.78%) on December 31, 2024.
- During the last 3 years, NTLA annual current liabilities has fallen by -$14.98 million (-11.91%).
- NTLA annual current liabilities is now -12.41% below its all-time high of $126.55 million, reached on December 31, 2022.
Performance
NTLA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$110.85 M
+$5.17 M+4.89%
December 31, 2024
Summary
- As of March 12, 2025, NTLA quarterly total current liabilities is $110.85 million, with the most recent change of +$5.17 million (+4.89%) on December 31, 2024.
- Over the past year, NTLA quarterly current liabilities has increased by +$12.94 million (+13.21%).
- NTLA quarterly current liabilities is now -15.47% below its all-time high of $131.13 million, reached on September 30, 2022.
Performance
NTLA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NTLA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | +13.2% |
| 3 y3 years | -11.9% | -11.9% |
| 5 y5 years | +211.1% | +211.1% |
NTLA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.4% | at low | -15.5% | +20.6% |
| 5 y | 5-year | -12.4% | +211.1% | -15.5% | +214.0% |
| alltime | all time | -12.4% | +4607.1% | -15.5% | +936.5% |
Intellia Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $110.85 M(-3.8%) | $110.85 M(+4.9%) |
| Sep 2024 | - | $105.68 M(+0.6%) |
| Jun 2024 | - | $105.09 M(+7.3%) |
| Mar 2024 | - | $97.91 M(-15.0%) |
| Dec 2023 | $115.21 M(-9.0%) | $115.21 M(+25.3%) |
| Sep 2023 | - | $91.95 M(-7.9%) |
| Jun 2023 | - | $99.85 M(-3.4%) |
| Mar 2023 | - | $103.38 M(-18.3%) |
| Dec 2022 | $126.55 M(+0.6%) | $126.55 M(-3.5%) |
| Sep 2022 | - | $131.13 M(+6.0%) |
| Jun 2022 | - | $123.76 M(-1.9%) |
| Mar 2022 | - | $126.11 M(+0.2%) |
| Dec 2021 | $125.83 M(+95.8%) | $125.83 M(+29.0%) |
| Sep 2021 | - | $97.57 M(+31.9%) |
| Jun 2021 | - | $73.96 M(+21.8%) |
| Mar 2021 | - | $60.70 M(-5.5%) |
| Dec 2020 | $64.25 M | $64.25 M(+15.0%) |
| Sep 2020 | - | $55.87 M(-5.5%) |
| Jun 2020 | - | $59.14 M(+67.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $35.30 M(-0.9%) |
| Dec 2019 | $35.63 M(-12.2%) | $35.63 M(-5.0%) |
| Sep 2019 | - | $37.52 M(-2.5%) |
| Jun 2019 | - | $38.46 M(-2.0%) |
| Mar 2019 | - | $39.23 M(-3.3%) |
| Dec 2018 | $40.57 M(+29.4%) | $40.57 M(+56.6%) |
| Sep 2018 | - | $25.91 M(+3.0%) |
| Jun 2018 | - | $25.17 M(-1.6%) |
| Mar 2018 | - | $25.58 M(-18.4%) |
| Dec 2017 | $31.36 M(+2.0%) | $31.36 M(+21.6%) |
| Sep 2017 | - | $25.79 M(-2.2%) |
| Jun 2017 | - | $26.37 M(+5.9%) |
| Mar 2017 | - | $24.91 M(-18.9%) |
| Dec 2016 | $30.73 M(+187.3%) | $30.73 M(+35.8%) |
| Sep 2016 | - | $22.63 M(+4.7%) |
| Jun 2016 | - | $21.62 M(+97.2%) |
| Mar 2016 | - | $10.96 M(+2.5%) |
| Dec 2015 | $10.70 M(+354.1%) | $10.70 M |
| Dec 2014 | $2.35 M | - |
FAQ
- What is Intellia Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics annual current liabilities year-on-year change?
- What is Intellia Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly current liabilities year-on-year change?
What is Intellia Therapeutics annual total current liabilities?
The current annual current liabilities of NTLA is $110.85 M
What is the all time high annual current liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high annual total current liabilities is $126.55 M
What is Intellia Therapeutics annual current liabilities year-on-year change?
Over the past year, NTLA annual total current liabilities has changed by -$4.36 M (-3.78%)
What is Intellia Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NTLA is $110.85 M
What is the all time high quarterly current liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly total current liabilities is $131.13 M
What is Intellia Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NTLA quarterly total current liabilities has changed by +$12.94 M (+13.21%)